Molecular Biology for the Non-Molecular Biologist Training Course (Apr 20–21, 2026)
Molecular Biology for the Non-Molecular Biologist training course, designed to elevate expertise in pharmaceuticals research, development, and manufacturing. This program provides professionals with practical knowledge of molecular biology, essential for understanding and manipulating DNA, RNA, and protein interactions that drive drug discovery, development, and personalized medicine. Its applications extend to biotechnology, microbiology, and the pharmaceutical industries.
Why Attend
Molecular biology is not just theoretical—it’s a vital tool for modern pharmaceutical professionals. As advanced molecular techniques become increasingly central to research and production, staying up to date with breakthroughs, technologies, and regulatory requirements is critical. This course equips participants with the knowledge and skills to excel in diverse roles across research, development, quality assurance, regulatory affairs, and manufacturing.
Participants will gain a solid foundation in molecular biology concepts, practical techniques, and insights into their pharmaceutical applications, ensuring they stay ahead in this fast-moving field.
Key Topics
- Central Dogma of molecular biology
- DNA replication and gene expression
- Molecular genetics and practical techniques
- Applications in medicine, biotechnology, and pharmaceuticals
Benefits of Attending
Participants will:
- Develop a deep understanding of molecular biology concepts and techniques critical for pharmaceutical applications.
- Learn about recent breakthroughs such as CRISPR-Cas9, single-cell sequencing, and mRNA vaccines, and their implications for drug discovery and development.
- Understand regulatory compliance for molecular biology applications in the pharmaceutical industry.
- Gain practical skills through hands-on techniques.
- Engage in discussions and critical analyses of recent research and case studies to apply knowledge effectively.
Certification
- CPD: 12 hours
- Certificate of Completion
Who Should Attend
This course is ideal for professionals with a scientific background seeking to strengthen their molecular biology knowledge in pharmaceutical and biotechnological contexts, including:
- Regulatory affairs professionals
- Quality assurance specialists
- Chemistry, Manufacturing and Control (CMC) specialists
- Clinical trial managers
- Pharmaceutical engineers and manufacturers
- Process engineers and developers
- Production managers
- Research & development personnel
- Clinical research coordinators
- Bioinformatic analysts
Course Agenda
Day 1: Principles of Molecular Biology
Principles I
- Central Dogma and the foundations of life
- Molecular cloning, library construction, PCR, and modern molecular biology techniques
- Regulatory considerations in molecular biology, including FDA and EMA compliance
- Regulatory pathways for molecular diagnostics and therapies
Principles II
- Omics, gene expression, and gene regulation in prokaryotes and eukaryotes
- Translating genes to proteins to patient applications
Practical Skills
- Gel electrophoresis, DNA isolation, molecular cloning, PCR
- Immunoblotting, protein purification, DNA/protein characterization
- Principles of Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) in research and production
Applications
- Molecular biology in disease diagnosis, personalized medicine, and genetic screening
- Forensics: police work and paternity testing
Day 2: Recent Breakthroughs and Applications
Innovations in Molecular Biology
- CRISPR-Cas9 gene editing and pharmaceutical research applications
- Single-cell sequencing for drug discovery
- mRNA vaccines, including their use in cancer therapy
- Regulatory guidance for these emerging technologies (FDA/EMA updates)
Molecular Biology in Medicine
- Understanding genetic disorders
- Identifying new drug targets
- Developing personalized and targeted therapies, with a focus on cancer
- Navigating clinical trials and regulatory approval processes
Molecular Biology in Biotechnology
- Genetically modified organisms (GMOs) and biopharmaceutical development
- Directed evolution for enzyme production and industrial enzyme applications
- Compliance and regulatory requirements for biopharmaceuticals, GMOs, and industrial enzymes
Practical Application Discussion
- Critical analysis of the four latest research articles in molecular biology
- Evaluating how regulatory science influences the development and approval of molecular biology products
Course Speaker
Dr. Sayed K. Goda – University of Derby
Dr. Goda is a distinguished professor in biochemistry and drug discovery with extensive experience in academic, commercial, and medical research. He earned a BSc in Chemistry and an MSc in Organic Chemistry from Cairo University, Egypt, followed by a PhD in Biochemistry from the University of Southampton, UK, and an MBA in Technology Management from the Open University, UK.
He spent 14 years at Porton Down, UK, as a senior scientist and team leader, conducting commercial and medically sensitive research, including protein engineering for novel therapeutics.
Dr. Goda has held professorships at Cairo University and Qatar University, establishing new biotechnology programs, supervising MSc and PhD candidates, and obtaining numerous research grants. He currently serves as a senior scientist and professor at the Anti-Doping Laboratory in Qatar, leading protein engineering research for cancer-targeting drug discovery.
He has secured over $2 million in research funding, collaborated with Groningen University, Netherlands, and published extensively. He also serves as a reviewer and guest editor for high-impact journals, including Cancers.
This comprehensive two-day training course provides both the theoretical understanding and practical tools necessary to excel in molecular biology applications for pharmaceuticals, biotechnology, and research. Attendees will leave with enhanced expertise, hands-on skills, and a clear understanding of regulatory considerations shaping the future of drug discovery and development.
Source Link : https://www.businesswire.com/
